XPOVIO Online Discussion

Interactive clinical discussion:

XPOVIO® (selinexor), Now approved as early as 1st relapse in multiple myeloma.

By: Joseph Mikhael, MD – Translational Genomics Research Institute

 

Virtual Program
https://tallen-inc.zoom.us/j/93984020923?pwd=QVdmWElmcDlEa0ZQUlAxVCtBa2Jodz09

 

RSVP:

866-914-9069

KaryopharmRSVP@pw.veeva.com

KAR0001187  – Please reference this number during registration

 

 

 

 

Date/Time
Date(s) - 02/03/21
6:00 pm - 7:00 pm
Contact/Email
Darcy Robson
602-770-6148
Downloads

About us

The Silicon Valley chapter of the Oncology Nursing Society is committed to provide mechanisms to further the professional development of the individual members within the chapter.

A secondary but equally important mission is to provide an atmosphere of collegial, professional and emotional support to the chapter membership throughout the continued transition in health care as it exists in the state of California and as it evolves throughout the nation..

Contact Info

a 503c Organization, Santa Clara, CA, USA